Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 5, 1996, Pages 406-416

  Andersson, Borje S ^a   Sadeghi, Tara ^a   Siciliano, Michael J ^a   Legerski, Randy ^a   Murray, David ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

4 Hydroperoxycyclophosphamide; Chinese hamster ovary cells; Cyclophosphamide; DNA crosslinks; DNA repair deficient mutants; Phosphorodiamidic mustard

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CISPLATIN; CYCLOPHOSPHAMIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CELL MUTANT; CHO CELL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CHO CELLS; CISPLATIN; CRICETINAE; CYCLOPHOSPHAMIDE; DNA REPAIR; FEMALE; GENES; PHOSPHORAMIDE MUSTARDS; TRANSFECTION;

EID: 0029773392     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050504     Document Type: Article

References (66)

1. DeVita VT, Hellman S, Rosenberg SA (1993) Cancer: principles and practice of oncology, 4th edn. Lippincott, Philadelphia
2. International Bone Marrow Transplant Registry, 1995
3. Sladek NE (1993) Oxazaphosphorine-specific acquired cellular resistance. In: Teicher BA (ed) Drug resistance in oncology. Marcel Dekker, New York, p 375
4. Hilton J (1984) Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res 44:5156
5. Crook TR, Souhami RL, Whyman GD, McLean AEM (1986) Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res 46:5035
6. McGown AT, Fox BW (1986) A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 17:223
7. Robson CN, Lewis AD, Wolf CR, Hayes JD, Hall A, Proctor SJ, Harris AL, Hickson IE (1987) Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glulathione S-transferase activity. Cancer Res 47:6022
8. Lewis AD, Hickson ID, Robson CN, Harris AL, Hayes JD, Griffiths SA, Manson MM, Hall AE, Moss JE, Wolf CR (1988) Amplification and increased expression of alpha class glutathione-S-transferase-encoding genes associated with resistance to nitrogen mustards. Proc Natl Acad Sci USA 85:8511
9. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313
10. Richardson ME, Siemann DW (1995) DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione. Cancer Res 55:1691
11. Greenbaum M, Letourneau S, Assar H, Schecter RL, Batist G, Cournoyer D (1994) Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts. Cancer Res 54:4442
12. Dirven HAAM, Ommen B van, Bladeren PJ van (1994) Involvement of human glutathione-S-transferase iso-enzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res 54:6215
13. Fox M, Roberts JJ (1987) Drug resistance and DNA repair. Cancer Metastasis. Rev 6:261
14. Calsou P, Salles B (1993) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother Pharmacol 32:85
15. Panasci L, Henderson D, Torres-Garcia SJ, Skalski V, Caplan S, Hutchinson M (1988) Transport, metabolism and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia. Cancer Res 48:1972
16. Torres-Garcia SJ, Cousineau L, Caplan S, Panasci L (1989) Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. Biochem. Pharmacol 38:3122
17. Batist G, Torres-Garcia S, Demuys J-M, Greene D, Lehnert S, Rochon M, Panasci L (1989) Enhanced DNA cross-link removal: The apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line. Mol Pharmacol 36:224
18. Geleziunas R, McQuillan A, Malapetsa A, Hutchinson M, Kopriva D, Wainberg MA, Hiscott J, Bramson J, Panasci L (1991) Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. J Natl Cancer Inst 83:557
19. Dabholkar M, Bostick-Bruton F, Weber C, Bohr WA, Egwuagu C, Reed E (1992) ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J Natl Cancer Inst 84: 1512
20. Andersson BS, Mroue M, Britten RA, Murray D (1994) The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogs. Cancer Res 54: 5394
21. Andersson BS, Mroue M, Britten RA, Farquhar D, Murray D (1995) Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line. Acta Oncol 34:247
22. Hoy CA, Thompson LH, Mooney CL, Salazar EP (1985) Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res 45:1737
23. Sorenson CM, Eastman A (1988) Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res 48:6703
24. Keiner MJ, McMorris TC, Estes L, Rutherford M, Montoya M, Goldstein J, Samson K, Starr R, Taetle R (1994) Characterization of Illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents. Biochem Pharmacol 48:403
25. Kaizer H, Stuart RK, Brookmeyer R, Beschorner WE, Braine HG, Burns WH, Fuller DJ, Korbling M, Mangan KF, Saral R, Sensenbrenner L, Shadduck RK, Shende AC, Tutschka PJ, Yeager AM, Zinkham WH, Colvin OM, Santos GW (1985) Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 65:1504
26. Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, Stratford May W, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR (1986) Autologous bone marrow transplantation in patients with acute non-lymphocytic leukemia using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. New Engl J Med 315:141
27. Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett A, Rizzoli V, Alessandrino EP, Bjorkstrand B, Ferrant A, Lowenberg B, Coser P, Simonsson B, Helbig W, Brunet Mauri S, Verdonck LF, Iriondo A, Polli E, Colombat P, Franklin IM, Souillet G, Willemze R (1991) Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. Leukemia 5:896
28. Wilmer JL, Erexson GL, Kligerman AD (1990) Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes. Cancer Res 50:4635
29. Thompson LH, Rubin JS, Cleaver JE, Whitmore GF, Brookman K (1980) A screening method for isolating DNA repair-deficient mutants of CHO cells. Somat Cell Genet 6:391
30. Thompson LH, Busch DB, Brookman K, Mooney CL, Glaser DA (1981) Genetic diversity of UV-sensitive DNA repair mutants of Chinese hamster ovary cells. Proc Natl Acad Sci USA 78:3734
31. Thompson LH, Brookman KW, Dillehay LE, Carrano AV, Mazrimas JA, Mooney CL, Minkler JL (1982) A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister chromatid exchange. Mutat Res 95:427
32. Liu P, Siciliano J, White B, Legerski R, Callen D, Reeders S, Siciliano MJ, Thompson LH (1993) Regional mapping of human DNA excision repair gene ERCC4 to chromosome 16p13.13-p13.2. Mutagenesis 8:199
33. Aruffo A, Seed B (1987) Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci USA 84:8573
34. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual (2nd edn). Cold Spring Harbor Laboratory Press, Plainview, New York
35. De Jong S, Zijlstra JG, Timmer-Bosscha H, Mulder NH, De Vries EGE (1986) Detection of DNA crosslinks in tumor cells with the ethidium bromide fluorescence assay. Int J Cancer 37:557
36. Kohn FR, Landkamer GJ, Manthey CL, Ramsay NKC, Sladek NE (1987) Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res 47:3180
37. Colvin M, Hilton J (1988) Cellular resistance to cyclophosphamide. In: Wooley PV, Tew KD (eds) Mechanisms of drug resistance in neoplastic cells. Academic Press, New York, p 161
38. Sreerama L, Sladek NE (1994) Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Cancer Res 54:2176
39. Rekha GK, Sreerama L, Sladek NE (1994) Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem Pharmacol 48:1943
40. Groot CJ de, Martens ACM, Hagenbeek A (1994) Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelcytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo. Eur J Cancer 30A:2137
41. Richardson ME, Siemann DW (1994) Thiol-related mechanisms of resistance in a murine tumor model. Int J Radiat Oncol Biol Phys 29:387
42. Parsons PG, Lean J, Kable EPW, Favier D, Khoo SK, Hurst T, Holmes RS, Bellet AJD (1990) Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines. Biochem Pharmacol 40:2641
43. Chen G, Waxman DJ (1995) Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Biochem Pharmacol 49:1691
44. Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW (1992) Cyclophosphamide resistance in medulloblastoma. Cancer Res 52:5373
45. Hoeijmakers JHJ (1993) Nucleotide excision repair II: from yeast to mammals. Trends Genet 9:211
46. Sancar A, Tang M-S (1993) Nucleotide excision repair. Photochem Photobiol 57:905
47. Thacker J, Wilkinson RE (1991) The genetic basis of resistance to ionising radiation damage in cultured mammalian cells. Mutat Res 254:135
48. Scanlon KJ, Kashani-Sabet M, Miyachi H, Sowers LC, Rossi J (1989) Molecular basis of cisplatin resistance in human carcinomas: model systems and patients. Anticancer Res 9:1301
49. Yang LY, Trujillo JM, Li L (1992) Enhanced expression of DNA polymerases α and β in acquired cisplatin-resistant human colon carcinoma cells. Procceeding 83rd AACR Meeting. San Diego, Calif. Abstract no. 2733
50. Scanlon KJ, Kashani-Sabet M (1988) Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells. Proc Natl Acad Sci 85:650
51. Bissett D, McLaughlin K, Kelland LR, Brown R (1993) Cisplatin-DNA damage recognition proteins in human tumour extracts. Br J Cancer 67:742
52. Kasparkova J, Brabek V (1995) Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins. Biochemistry 34:12379
53. Crook TR, Souhami RL, McLean AEM (1986) Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells. Cancer Res 46:5029
54. Weeda G, Hoeijmakers JHJ (1993) Genetic analysis of nucleotide excision repair in mammalian cells. Semin Cancer Biol 4:105
55. Vuuren AJ van, Appeldoorn E, Odijk H, Yasui A, Jaspers NGJ, Bootsma D, Hoeijmakers JHJ (1993) Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F. EMBO J 12:3693
56. Biggerstaff M, Szymkowski DE, Wood RD (1993) Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J 12:3685
57. Li L, Elledge JS, Peterson CA, Bales ES, Legerski RJ (1994) Specific association between the human DNA repair proteins XPA and ERCC1. Proc Natl Acad Sci USA 91:5012
58. Chi-Hyun P, Sancar A (1994) Formation of a ternary complex by human XPA, ERCC1, and ERCC4 (XPF) excision repair proteins. Proc Natl Acad Sci USA 91:5017
59. Erickson LC, Ramonas LM, Zaharko DS, Kohn KW (1980) Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Cancer Res 40: 4216
60. Hilton J (1984) Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells. Biochem Pharmacol 33:1867
61. Ross WE, Ewig RA, Kohn KW (1978) Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links. Cancer Res 38:1502
62. Taylor YC, Evans JW, Brown JM (1982) Mechanism of sensitization by hypoxic pretreatment with misonidazole. Radiat Res 91:379
63. Murray D, Meyn RE (1983) Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo. Br J Cancer 47:195
64. Thompson LH, Brookman KW, Weber CA, Salazar EP, Reardon JT, Sancar A, Deng Z, Siciliano MJ (1994) Molecular cloning of the human nucleotide-excision-repair gene ERCC4. Proc Natl Acad Sci USA 91:6855
65. Hanania EG, Deisseroth AB (1994) Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther 1:21
66. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99